Glenn Hernández is an Intensivist and Full Professor at the Pontificia Universidad Católica de Chile, with expertise in systemic and regional perfusion, resuscitation and management of septic shock. He was the Principal Investigator of the ANDROMEDA-SHOCK trial, which compared CRT- versus lactate-targeted resuscitation in early septic shock.